<p>Harold H. Shlevin, Director, reported a disposal of common shares of Galectin Therapeutics Inc. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galectin Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001133416-25-000061), on December 10, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

GALT

<p>Harold H. Shlevin, Director of Galectin Therapeutics Inc., reported the disposal of common shares. The information was published via EDGAR by the U.S. Securities and Exchange Commission on December 10, 2025. This brief was created by Public Technologies using AI and is for informational purposes only.</p>

Galectin Therapeutics Director Harold H. Shlevin Reports Disposal of Common Shares